Does IFOSFAMIDE Cause Product use in unapproved indication? 890 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 890 reports of Product use in unapproved indication have been filed in association with IFOSFAMIDE (IFEX). This represents 5.2% of all adverse event reports for IFOSFAMIDE.
890
Reports of Product use in unapproved indication with IFOSFAMIDE
5.2%
of all IFOSFAMIDE reports
190
Deaths
183
Hospitalizations
How Dangerous Is Product use in unapproved indication From IFOSFAMIDE?
Of the 890 reports, 190 (21.3%) resulted in death, 183 (20.6%) required hospitalization, and 82 (9.2%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 890 reports have been filed with the FAERS database.
What Other Side Effects Does IFOSFAMIDE Cause?
Off label use (2,281)
Febrile neutropenia (2,225)
Disease progression (1,912)
Neutropenia (1,509)
Drug ineffective (1,331)
Thrombocytopenia (1,227)
Anaemia (1,067)
Pyrexia (752)
Sepsis (712)
Malignant neoplasm progression (671)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which IFOSFAMIDE Alternatives Have Lower Product use in unapproved indication Risk?
IFOSFAMIDE vs IGURATIMOD
IFOSFAMIDE vs ILOPERIDONE
IFOSFAMIDE vs ILOPROST
IFOSFAMIDE vs IMATINIB
IFOSFAMIDE vs IMBRUVICA